Rhodiola rosea — Arctic root extract standardised to the classic 3:1 rosavin/salidroside ratio, supplied for endurance and fatigue-resistance formulations.
Rhodiola rosea root extract is supplied standardised to 3% rosavins and 1% salidroside — the 3:1 ratio most consistently referenced in endurance and fatigue-resistance formulations, rather than a rosavin-only figure that overstates the active profile.
It's sold as a fine powder, and every batch carries a certificate of analysis confirming both markers by HPLC alongside heavy metal, microbial and pesticide screening. See Quality Assurance for the full testing process.
The most common use case — often paired with Cordyceps Militaris in fatigue-resistance and stamina-focused stacks.
Also formulated into general stress-support stacks alongside Ashwagandha, where the two extracts' evidence bases differ enough to complement rather than duplicate.
The most common use case — often paired with Cordyceps Militaris in fatigue-resistance and stamina-focused stacks.
Also formulated into general stress-support stacks alongside Ashwagandha, where the two extracts' evidence bases differ enough to complement rather than duplicate.
Trade buyers increasingly need to answer sourcing questions themselves — here's what we can tell you about this specific ingredient.
Processed at a GMP-certified EU facility, audited on our own schedule rather than taken on trust from a spec sheet — see Quality Assurance.
Rhodiola rosea faces genuine wild-harvesting pressure across parts of its native range. We source a wild-and-cultivated blend specifically to reduce reliance on wild stock.
Sourced through ongoing relationships with EU-based processors rather than opportunistic spot-buying, supporting both consistency and traceable origin.
Every batch is traceable back to its processing facility and source mix — ask if you need the wild/cultivated split documented for a specific batch.
Processed at a GMP-certified EU facility, audited on our own schedule rather than taken on trust from a spec sheet — see Quality Assurance.
Rhodiola rosea faces genuine wild-harvesting pressure across parts of its native range. We source a wild-and-cultivated blend specifically to reduce reliance on wild stock.
Sourced through ongoing relationships with EU-based processors rather than opportunistic spot-buying, supporting both consistency and traceable origin.
Every batch is traceable back to its processing facility and source mix — ask if you need the wild/cultivated split documented for a specific batch.
General safety information for trade buyers and formulators — not medical advice, and not a substitute for your own regulatory and safety assessment. See the full Warnings & Safety Information page for the complete catalogue reference.
| Consideration | Detail |
|---|---|
| Stimulant timing | Mild stimulant effect — best avoided in evening or sleep-support formulations. |
| Medication interactions | May interact with MAOI (monoamine oxidase inhibitor) medication. Flag clearly where relevant to your formulation. |
| Mental health conditions | Stimulating effect means general caution for anxiety disorders or bipolar-spectrum conditions; not typically recommended without professional guidance in these cases. |
| Pregnancy & breastfeeding | Not recommended during pregnancy or breastfeeding, consistent with most adaptogens lacking extensive safety data in these populations. |
Mild stimulant effect — best avoided in evening or sleep-support formulations.
May interact with MAOI (monoamine oxidase inhibitor) medication. Flag clearly where relevant to your formulation.
Stimulating effect means general caution for anxiety disorders or bipolar-spectrum conditions; not typically recommended without professional guidance in these cases.
Not recommended during pregnancy or breastfeeding, consistent with most adaptogens lacking extensive safety data in these populations.
It's the ratio most consistently referenced in Rhodiola research and the specification buyers most often ask for by name. A rosavin-only figure without a stated salidroside content usually signals a less rigorously standardised extract.
Supply is a wild and cultivated blend sourced from the EU, standardised to the same 3% rosavin / 1% salidroside specification regardless of source mix. Ask if you need confirmation of the exact sourcing split for a specific batch.
By HPLC, per batch, with both markers reported separately on the certificate of analysis — not a combined figure that could obscure a low salidroside content.
It follows the standard Starter tier from 1–10kg/month — see Wholesale & Trade Accounts for the full tier structure.
See the Safety & Risk Information above for known considerations, particularly around MAOI medication. This isn't medical advice — consumer-facing products should carry appropriate guidance to consult a healthcare professional.
Tell us your target volume and we'll come back with pricing and the current batch certificate of analysis.